The genetic predispositions of defective BRCA1 and/or BRCA2 (the second most common mutations in ovarian cancer) genes are responsible for only 10–20% of all ovarian cancer cases, with the genetic marker increasing a patient’s risk by 15–60% [7,27]. This evidence concerns the gene BRCA2 and ovarian carcinoma.